Importer of Controlled Substances Registration, 2577 [2019-01519]
Download as PDF
<![CDATA[
2577
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUMMARY:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
The
companies listed below applied to be
registered as importers of various basic
SUPPLEMENTARY INFORMATION:
Notice of registration.
Company
FR docket
Noramco Inc ......................................................................................................................................................
Catalent CTS, LLC ............................................................................................................................................
United States Pharmacopeial Convention ........................................................................................................
Fisher Clinical Services, Inc .............................................................................................................................
Cambrex High Point, Inc ...................................................................................................................................
Sharp (Bethlehem), LLC ...................................................................................................................................
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each of the company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
83
83
83
83
83
83
FR
FR
FR
FR
FR
FR
53107
54613
54611
54612
54610
54612
The
companies listed below applied to be
registered as bulk manufacturers of
various basic classes of controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
83 FR 48334
83 FR 49578
Jkt 247001
2018.
2018.
2018.
2018.
2018.
2018.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–01519 Filed 2–6–19; 8:45 am]
AMPAC Fine Chemicals Virginia, LLC ..........................................................................................................
AMPAC Fine Chemicals, LLC .......................................................................................................................
17:23 Feb 06, 2019
19,
30,
30,
30,
30,
30,
The registrants listed below
has applied for and has been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturer of various classes of
schedule I and II controlled substances.
FR Docket
VerDate Sep<11>2014
October
October
October
October
October
October
SUMMARY:
Company
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing their physical
security systems, verifying their
compliance with state and local laws,
and reviewing each of the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
Published
registration as a bulk manufacturer to
the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–01525 Filed 2–6–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 2018–43]
Kurt L. Pflieger, M.D.; Order
Dismissing Order To Show Cause
On July 12, 2018, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Published
September 24, 2018.
October 2, 2018.
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause to Kurt L. Pflieger, M.D.
(hereinafter, Respondent), of Rockwall,
Texas. Order to Show Cause
(hereinafter, OSC), at 1. The OSC
proposes the revocation of Respondent’s
Certificate of Registration on the ground
that he does not have authority to
handle controlled substances in the
State of Texas, the State in which he is
registered with the DEA. Id.
After the Administrative Law Judge
(hereinafter, ALJ) certified and
transmitted the record to me along with
his Recommended Decision, the
Government submitted a ‘‘Motion to
Dismiss Order to Show Cause’’
(hereinafter, Motion). According to the
Motion, the Texas Medical Board held
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01519]
[[Page 2577]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Noramco Inc................. 83 FR 53107 October 19, 2018.
Catalent CTS, LLC........... 83 FR 54613 October 30, 2018.
United States Pharmacopeial 83 FR 54611 October 30, 2018.
Convention.
Fisher Clinical Services, 83 FR 54612 October 30, 2018.
Inc.
Cambrex High Point, Inc..... 83 FR 54610 October 30, 2018.
Sharp (Bethlehem), LLC...... 83 FR 54612 October 30, 2018.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each of the company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01519 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P
